1. Home
  2. OBIO vs ASG Comparison

OBIO vs ASG Comparison

Compare OBIO & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
  • ASG
  • Stock Information
  • Founded
  • OBIO 2017
  • ASG 1986
  • Country
  • OBIO United States
  • ASG United States
  • Employees
  • OBIO N/A
  • ASG N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • ASG Investment Managers
  • Sector
  • OBIO Health Care
  • ASG Finance
  • Exchange
  • OBIO Nasdaq
  • ASG Nasdaq
  • Market Cap
  • OBIO 291.7M
  • ASG 310.9M
  • IPO Year
  • OBIO N/A
  • ASG N/A
  • Fundamental
  • Price
  • OBIO $8.03
  • ASG $5.56
  • Analyst Decision
  • OBIO Strong Buy
  • ASG
  • Analyst Count
  • OBIO 2
  • ASG 0
  • Target Price
  • OBIO $17.00
  • ASG N/A
  • AVG Volume (30 Days)
  • OBIO 247.1K
  • ASG 324.3K
  • Earning Date
  • OBIO 08-08-2024
  • ASG 01-01-0001
  • Dividend Yield
  • OBIO N/A
  • ASG 8.09%
  • EPS Growth
  • OBIO N/A
  • ASG N/A
  • EPS
  • OBIO N/A
  • ASG N/A
  • Revenue
  • OBIO $2,216,000.00
  • ASG N/A
  • Revenue This Year
  • OBIO $17.90
  • ASG N/A
  • Revenue Next Year
  • OBIO $10.51
  • ASG N/A
  • P/E Ratio
  • OBIO N/A
  • ASG N/A
  • Revenue Growth
  • OBIO N/A
  • ASG N/A
  • 52 Week Low
  • OBIO $4.22
  • ASG $4.47
  • 52 Week High
  • OBIO $11.69
  • ASG $5.71
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 54.76
  • ASG 65.69
  • Support Level
  • OBIO $7.48
  • ASG $5.19
  • Resistance Level
  • OBIO $8.75
  • ASG $5.69
  • Average True Range (ATR)
  • OBIO 0.60
  • ASG 0.06
  • MACD
  • OBIO 0.01
  • ASG 0.02
  • Stochastic Oscillator
  • OBIO 59.03
  • ASG 65.38

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

Share on Social Networks: